Market revenue in 2023 | USD 480.9 million |
Market revenue in 2030 | USD 1,712.0 million |
Growth rate | 19.9% (CAGR from 2023 to 2030) |
Largest segment | Tavr (transcatheter aortic valve replacement) |
Fastest growing segment | LAAC (Left Atrial Appendage Closure) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | SAVR (Surgical Aortic Valve Replacement), TAVR (Transcatheter Aortic Valve Replacement), Mitral Repair (Annuloplasty), LAAC (Left Atrial Appendage Closure) |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Edwards Lifesciences Corp, Abbott Laboratories, St. Jude Medical, LivaNova PLC, Stryker Corp, Lepu Medical, Biomerics, CardioKinetix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to structural heart devices market will help companies and investors design strategic landscapes.
Tavr (transcatheter aortic valve replacement) was the largest segment with a revenue share of 62.47% in 2023. Horizon Databook has segmented the India structural heart devices market based on savr (surgical aortic valve replacement), tavr (transcatheter aortic valve replacement), mitral repair (annuloplasty), laac (left atrial appendage closure) covering the revenue growth of each sub-segment from 2018 to 2030.
India is experiencing a significant increase in the number of cardiovascular diseases, with a considerable portion being attributed to valvular heart disease. The growing health concern has led to a demand for effective treatment options.
Despite the need, awareness regarding minimally invasive structural heart devices among patients and healthcare providers is slowly increasing, contributing to the market's expansion. Moreover, advancements in healthcare infrastructure, notably the emergence of specialized cardiac centers, are conducive to the proliferation of these procedures.
TAVR stands out as a pivotal therapy for individuals with severe AS, a condition burdening India extensively, whether rheumatic or non-rheumatic. However, the pace of TAVR adoption in India lags due to multifaceted challenges.
Horizon Databook provides a detailed overview of country-level data and insights on the India structural heart devices market , including forecasts for subscribers. This country databook contains high-level insights into India structural heart devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account